Table 2. Diagnostic Potential of Exosome-Related lncRNAs as Biomarkers.
| cancer | LncRNA | expression levels | AUC | sensitivity (%) | specificity (%) | sample size | source | application direction | quote |
|---|---|---|---|---|---|---|---|---|---|
| gastric cancer | FRLnc1 | up | 0.863 | 80.60 | 76.90 | 82 (52GC/30HC) | blood | cancer diagnosis | (81) |
| triple negative breast cancer | exo-XIST | up | 0.888 | 84.20 | 92.30 | 141 (91TNBC/50HC) | blood | recurrence and progression prediction | (82) |
| colon cancer | FOXD2-AS1 | up | 0.728 | 72.60 | 62.30 | 404 (203CRC/201HC) | blood | early cancer diagnosis | (83) |
| 0.743 | 70.60 | 59.40 | 281 (80 early CRC/201HC) | ||||||
| cervical cancer | DLX6-AS1 | up | 0.892 | 78.10 | 88.20 | 224(114CC/110HC) | blood | cancer diagnosis | (84) |
| 0.831 | 75.40 | 71.80 | 174 (114CC/60CIN) | benign and malignant identification | |||||
| lung cancer | SNHG15 | up | 0.856 | 198 (118NSCLC/80HC) | blood | diagnosis and prognosis | (85) | ||
| liver cancer | CRNDE | up | 0.839 | 69.30 | 85.00 | 266 (166HCC/100HC) | blood | cancer diagnosis | (86) |